NASDAQ:STAA - STAAR Surgical Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $84.25
  • Forecasted Upside: -43.14 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$148.16
▲ +2.68 (1.84%)

This chart shows the closing price for STAA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New STAAR Surgical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for STAA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for STAA

Analyst Price Target is $84.25
▼ -43.14% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for STAAR Surgical in the last 3 months. The average price target is $84.25, with a high forecast of $150.00 and a low forecast of $58.00. The average price target represents a -43.14% upside from the last price of $148.16.

This chart shows the closing price for STAA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 5 polled investment analysts is to hold stock in STAAR Surgical. This rating changed within the last month from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/29/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/28/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/26/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
9/24/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
12/23/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
3/23/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/22/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/6/2021Canaccord GenuityBoost Price TargetBuy$128.00 ➝ $150.00High
2/25/2021Canaccord GenuityBoost Price TargetBuy$84.00 ➝ $128.00High
2/8/2021BTIG ResearchReiterated RatingHoldHigh
1/19/2021BenchmarkDowngradeBuy ➝ HoldLow
11/5/2020Canaccord GenuityBoost Price TargetBuy$70.00 ➝ $84.00High
10/26/2020SidotiDowngradeBuy ➝ NeutralHigh
8/31/2020SidotiUpgradeNeutral ➝ Buy$58.00High
8/28/2020BTIG ResearchReiterated RatingHoldLow
8/6/2020BenchmarkBoost Price TargetBuy$50.00 ➝ $66.00High
7/8/2020Canaccord GenuityBoost Price TargetBuy$45.00 ➝ $70.00Low
7/8/2020StephensBoost Price TargetOverweight$45.00 ➝ $63.00Low
7/6/2020BTIG ResearchReiterated RatingHoldLow
7/6/2020SidotiDowngradeBuy ➝ Neutral$58.00High
6/24/2020BTIG ResearchReiterated RatingBuy ➝ NeutralHigh
6/15/2020Jefferies Financial GroupInitiated CoverageBuy$55.00High
5/7/2020Canaccord GenuityReiterated RatingBuyMedium
5/6/2020BTIG ResearchReiterated RatingBuy$41.00Medium
4/14/2020Canaccord GenuityLower Price TargetBuy$48.00 ➝ $44.00High
3/23/2020StephensLower Price TargetOverweight$56.00 ➝ $37.00Medium
3/10/2020BTIG ResearchReiterated RatingBuy$46.00High
1/2/2020StephensReiterated RatingBuy$56.00Low
12/4/2019BTIG ResearchInitiated CoverageBuy$46.00High
11/11/2019Canaccord GenuityBoost Price TargetBuy$40.00 ➝ $45.00Low
5/6/2019Canaccord GenuityReiterated RatingBuy$43.00 ➝ $38.00High
9/24/2018BenchmarkReiterated RatingBuy ➝ Buy$45.00 ➝ $54.00Medium
9/14/2018Canaccord GenuityBoost Price TargetBuy$43.00 ➝ $55.00High
8/6/2018BenchmarkInitiated CoverageBuy$45.00High
8/2/2018Canaccord GenuityReiterated RatingBuy$32.00 ➝ $43.00High
6/20/2018Canaccord GenuityReiterated RatingBuy ➝ Buy$23.00 ➝ $32.00High
5/3/2018Canaccord GenuityBoost Price TargetBuy ➝ Buy$21.00 ➝ $23.00High
5/3/2018StephensUpgradeEqual Weight ➝ Overweight$13.00 ➝ $21.00High
4/30/2018William BlairUpgradeMarket Perform ➝ OutperformMedium
4/24/2018Canaccord GenuityReiterated RatingBuy$21.00Medium
11/20/2017BenchmarkReiterated RatingBuy ➝ Buy$21.00N/A
11/17/2017Canaccord GenuityBoost Price TargetBuy$17.50 ➝ $20.00N/A
10/20/2017BenchmarkBoost Price TargetBuy$13.00 ➝ $15.00N/A
10/8/2017Canaccord GenuityReiterated RatingBuy$15.00N/A
9/25/2017Canaccord GenuityUpgradeHold ➝ Buy$15.00High
9/6/2017Canaccord GenuityReiterated RatingHold$11.00Low
8/14/2017BenchmarkBoost Price TargetBuy ➝ Buy$12.00 ➝ $13.00Medium
8/3/2017Canaccord GenuityBoost Price TargetHold$9.00 ➝ $11.00Low
7/11/2017Canaccord GenuityReiterated RatingHoldLow
3/3/2017BenchmarkReiterated RatingBuy ➝ Buy$10.00 ➝ $12.00N/A
3/3/2017Canaccord GenuityReiterated RatingHold$9.00N/A
11/6/2016BenchmarkSet Price TargetBuy$10.00N/A
8/4/2016William BlairReiterated RatingMarket PerformN/A
(Data available from 6/21/2016 forward)
STAAR Surgical logo
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Read More

Today's Range

Now: $148.16
Low: $140.94
High: $148.25

50 Day Range

MA: $131.25
Low: $106.27
High: $151.15

52 Week Range

Now: $148.16
Low: $45.47
High: $154.45

Volume

355,964 shs

Average Volume

657,145 shs

Market Capitalization

$6.95 billion

P/E Ratio

673.49

Dividend Yield

N/A

Beta

0.99

Frequently Asked Questions

What sell-side analysts currently cover shares of STAAR Surgical?

The following sell-side analysts have issued reports on STAAR Surgical in the last twelve months: Benchmark Co., BTIG Research, Canaccord Genuity, Sidoti, Stephens, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for STAA.

What is the current price target for STAAR Surgical?

4 Wall Street analysts have set twelve-month price targets for STAAR Surgical in the last year. Their average twelve-month price target is $84.25, suggesting a possible downside of 42.1%. Canaccord Genuity has the highest price target set, predicting STAA will reach $150.00 in the next twelve months. Sidoti has the lowest price target set, forecasting a price of $58.00 for STAAR Surgical in the next year.
View the latest price targets for STAA.

What is the current consensus analyst rating for STAAR Surgical?

STAAR Surgical currently has 3 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in STAA, but not buy more shares or sell existing shares.
View the latest ratings for STAA.

What other companies compete with STAAR Surgical?

How do I contact STAAR Surgical's investor relations team?

STAAR Surgical's physical mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The medical instruments supplier's listed phone number is 626-303-7902 and its investor relations email address is [email protected] The official website for STAAR Surgical is www.staar.com.